Gen9
私人持有Gen9 由麻省理工學院Joseph Jacobson2009年創建,它已經開發的基因合成技術,可實現比先前方法更低成本、更高精度,以高通量、自動化方式合成DNA結構。它的BioFab平臺能夠合成數萬成千上萬的基因片段,同時所需的實驗室空間僅需幾平方英尺。
Gen9 is building on advances in synthetic biology to power a scalable fabrication capability that will significantly increase the world’s capacity to produce DNA content. The privately held company’s next-generation gene synthesis technology allows for the high-throughput, automated production of DNA constructs at lower cost and higher accuracy than previous methods on the market. Founded by world leaders in synthetic biology, Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels. Gen9 is based in Cambridge, Mass.